Why the study?
Paroxysmal atrial fibrillation can progress to stable forms with increased adverse outcomes, making prediction tools potentially useful for identifying high-risk patients.
Can risk stratification scales accurately predict the progression of atrial fibrillation or its recurrence after treatment?
Can risk stratification scales accurately predict the progression of atrial fibrillation or its recurrence after treatment?
Current risk stratification scales for atrial fibrillation progression have limited predictive value and rely on heterogeneous variables, underscoring the need for improved predictive models.
Answers are grounded in this paper and cite their sources.
Existing AF risk scales warrant cautious use given limited accuracy; leaves open development of superior predictive models.
Paroxysmal atrial fibrillation can progress over time to stable forms, which is associated with an increased risk of adverse events and outcomes. The use of prediction tools for arrhythmia progression may be useful in identifying highrisk patients. The review considers eight scales for stratifying the risk of atrial fibrillation progression, alongside with their comparative analysis. The main risk factors for arrhythmia recurrence and its transition to a permanent form are described. The obtained results show that these scales are characterized by the heterogeneity of the assessed variables, which dictates the need to create new diagnostic tools.
No takes yet. Share an insight, caveat, or question.
Snezhitskiy et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: